BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22056743)

  • 1. Synthesis of sulfonamide-containing N-hydroxyindole-2-carboxylates as inhibitors of human lactate dehydrogenase-isoform 5.
    Granchi C; Roy S; Mottinelli M; Nardini E; Campinoti F; Tuccinardi T; Lanza M; Betti L; Giannaccini G; Lucacchini A; Martinelli A; Macchia M; Minutolo F
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7331-6. PubMed ID: 22056743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation.
    Granchi C; Roy S; De Simone A; Salvetti I; Tuccinardi T; Martinelli A; Macchia M; Lanza M; Betti L; Giannaccini G; Lucacchini A; Giovannetti E; Sciarrillo R; Peters GJ; Minutolo F
    Eur J Med Chem; 2011 Nov; 46(11):5398-407. PubMed ID: 21944286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galloflavin (CAS 568-80-9): a novel inhibitor of lactate dehydrogenase.
    Manerba M; Vettraino M; Fiume L; Di Stefano G; Sartini A; Giacomini E; Buonfiglio R; Roberti M; Recanatini M
    ChemMedChem; 2012 Feb; 7(2):311-7. PubMed ID: 22052811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells.
    Granchi C; Roy S; Giacomelli C; Macchia M; Tuccinardi T; Martinelli A; Lanza M; Betti L; Giannaccini G; Lucacchini A; Funel N; León LG; Giovannetti E; Peters GJ; Palchaudhuri R; Calvaresi EC; Hergenrother PJ; Minutolo F
    J Med Chem; 2011 Mar; 54(6):1599-612. PubMed ID: 21332213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
    Güzel O; Temperini C; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem Lett; 2008 Jan; 18(1):152-8. PubMed ID: 18024029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-linear, non-competitive inhibition of lactate dehydrogenase with carboxylic acid anions (substrate analogues)].
    Saburova EA; Gol'dshteĭn BN; Elfimova LI; Vol'kenshteĭn MV
    Mol Biol (Mosk); 1982; 16(6):1173-82. PubMed ID: 7155138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the differential action on cancer cells of LDH-A inhibitors based on the N-hydroxyindole-2-carboxylate (NHI) and malonic (Mal) scaffolds.
    Granchi C; Calvaresi EC; Tuccinardi T; Paterni I; Macchia M; Martinelli A; Hergenrother PJ; Minutolo F
    Org Biomol Chem; 2013 Oct; 11(38):6588-96. PubMed ID: 23986182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-(3-biaryloxy-2-oxopropyl)indole-5-carboxylic acids and related compounds as dual inhibitors of human cytosolic phospholipase A2α and fatty acid amide hydrolase.
    Zahov S; Drews A; Hess M; Schulze Elfringhoff A; Lehr M
    ChemMedChem; 2011 Mar; 6(3):544-9. PubMed ID: 21259444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-molecule inhibitors of human LDH5.
    Granchi C; Paterni I; Rani R; Minutolo F
    Future Med Chem; 2013 Oct; 5(16):1967-91. PubMed ID: 24175747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclohex-1-ene carboxylic acids: synthesis and biological evaluation of novel inhibitors of human 5 alpha reductase.
    Baston E; Salem OI; Hartmann RW
    Arch Pharm (Weinheim); 2003 Mar; 336(1):31-8. PubMed ID: 12666251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
    Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
    J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and SAR of highly selective MMP-13 inhibitors.
    Li J; Rush TS; Li W; DeVincentis D; Du X; Hu Y; Thomason JR; Xiang JS; Skotnicki JS; Tam S; Cunningham KM; Chockalingam PS; Morris EA; Levin JI
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4961-6. PubMed ID: 16153831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors.
    Xiang Y; Hirth B; Asmussen G; Biemann HP; Bishop KA; Good A; Fitzgerald M; Gladysheva T; Jain A; Jancsics K; Liu J; Metz M; Papoulis A; Skerlj R; Stepp JD; Wei RR
    Bioorg Med Chem Lett; 2011 May; 21(10):3050-6. PubMed ID: 21507633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of some 5-phenylisoxazole-3-carboxylic acid derivatives as potent xanthine oxidase inhibitors.
    Wang S; Yan J; Wang J; Chen J; Zhang T; Zhao Y; Xue M
    Eur J Med Chem; 2010 Jun; 45(6):2663-70. PubMed ID: 20189693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative inhibitory activity of 3'- and 5'-functionalized nucleosides on ribonuclease A.
    Debnath J; Dasgupta S; Pathak T
    Bioorg Med Chem; 2010 Dec; 18(23):8257-63. PubMed ID: 21041096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxamic acid analogues as LDH-C4-specific competitive inhibitors.
    Rodríguez-Páez L; Chena-Taboada MA; Cabrera-Hernández A; Cordero-Martínez J; Wong C
    J Enzyme Inhib Med Chem; 2011 Aug; 26(4):579-86. PubMed ID: 21438710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of oxamic acid libraries: antimalarials and inhibitors of Plasmodium falciparum lactate dehydrogenase.
    Choi SR; Beeler AB; Pradhan A; Watkins EB; Rimoldi JM; Tekwani B; Avery MA
    J Comb Chem; 2007; 9(2):292-300. PubMed ID: 17316052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenase.
    Dragovich PS; Fauber BP; Corson LB; Ding CZ; Eigenbrot C; Ge H; Giannetti AM; Hunsaker T; Labadie S; Liu Y; Malek S; Pan B; Peterson D; Pitts K; Purkey HE; Sideris S; Ultsch M; VanderPorten E; Wei B; Xu Q; Yen I; Yue Q; Zhang H; Zhang X
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3186-94. PubMed ID: 23628333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of Toxoplasma gondii LDH1: active-site differences from human lactate dehydrogenases and the structural basis for efficient APAD+ use.
    Kavanagh KL; Elling RA; Wilson DK
    Biochemistry; 2004 Feb; 43(4):879-89. PubMed ID: 14744130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum.
    Deck LM; Royer RE; Chamblee BB; Hernandez VM; Malone RR; Torres JE; Hunsaker LA; Piper RC; Makler MT; Vander Jagt DL
    J Med Chem; 1998 Sep; 41(20):3879-87. PubMed ID: 9748363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.